γH2AX and cancer

Nature Reviews Cancer

Volumn 8, Issue 12, 2008, Pages 957-967

  Bonner, William M ^a   Redon, Christophe E ^a   Dickey, Jennifer S ^a   Nakamura, Asako J ^a   Sedelnikova, Olga A ^a   Solier, Stéphanie ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; AMINOFLAVONE; ANTINEOPLASTIC AGENT; AZACITIDINE; BATRACYLIN; BLEOMYCIN; CAMPTOTHECIN; CARBAZOLE DERIVATIVE; CISPLATIN; CYTARABINE; DNA DEPENDENT PROTEIN KINASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; HISTONE H2AX; HISTONE H2AX GAMMA; HYDROXYUREA; IMATINIB; INDENOISOQUINOLINE DERIVATIVE; INDOLOCARBAZOLE; ISOQUINOLINE DERIVATIVE; MELPHALAN; MITOXANTRONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; REACTIVE OXYGEN METABOLITE; TEMOZOLOMIDE; TIRAPAZAMINE; TRABECTEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORINOSTAT; H2AFX PROTEIN, HUMAN; HISTONE;

CANCER CELL; CANCER RISK; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL KILLING; DNA PROTEIN COMPLEX; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; DRUG SYNTHESIS; EXCISION REPAIR; HUMAN; IONIZING RADIATION; NEOPLASM; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DNA DAMAGE; GENETICS; MAMMAL; MOLECULAR GENETICS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; HISTONES; HUMANS; MAMMALS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PRECANCEROUS CONDITIONS; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 57149136324     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2523     Document Type: Review

References (167)

1. McKinnon, P. J. & Caldecott, K. W. DNA strand break repair and human genetic disease. Annu. Rev. Genomics Hum. Genet. 8, 37-55 (2007).
2. Jeggo, P. A. & Lobrich, M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 26, 7717-7719 (2007).
3. Hakem, R. DNA-damage repair; the good, the bad, and the ugly. EMBO J. 27, 589-605 (2008).
4. O'Driscoll, M., Gennery, A. R., Seidel, J., Concannon, P. & Jeggo, P. A. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst.) 3, 1227-1235 (2004).
5. Rogakou, E. P., Boon, C., Redon, C. & Bonner, W. M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916 (1999).
6. Helleday, T., Petermann, E., Lundin, C., Hodgson, B. & Sharma, R. A. DNA repair pathways as targets for cancer therapy. Nature Rev. Cancer 8, 193-204 (2008).
7. Takahashi, A. & Ohnishi, T. Does γH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett. 229, 171-179 (2005).
8. Sedelnikova, O. A., Pilch, D. R., Redon, C. & Bonner, W. M. Histone H2AX in DNA damage and repair. Cancer Biol. Ther. 2, 233-235 (2003).
9. Sedelnikova, O. A. & Bonner, W. M. γH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle 5, 2909-2913 (2006).
10. Kinner, A., Wu, W., Staudt, C. & Iliakis, G. γH2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 36, 5678-5694 (2008).
11. Wang, B. & Elledge, S. J. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl Acad. Sci. USA 104, 20759-20763 (2007).
12. Kolas, N. K. et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640 (2007).
13. Bartova, E., Krejci, J., Harnicarova, A., Galiova, G. & Kozubek, S. Histone modifications and nuclear architecture: a review. J. Histochem. Cytochem. 56, 711-721 (2008).
14. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (1998).
15. Levine, B. J., Chodchoy, N., Marzluff, W. F. & Skoultchi, A. I. Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc. Natl Acad. Sci. USA 84, 6189-6193 (1987).
16. Wu, R. S. & Bonner, W. M. Separation of basal histone synthesis from S-phase histone synthesis in dividing cells. Cell 27, 321-330 (1981).
17. Mannironi, C., Bonner, W. M. & Hatch, C. L. H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3′ processing signals. Nucleic Acids Res. 17, 9113-9126 (1989).
18. Mailand, N. et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900 (2007).
19. Kruhlak, M. J. et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J. Cell Biol. 172, 823-834 (2006).
20. Paull, T. T. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886-895 (2000).
21. Shroff, R. et al. Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr. Biol. 14, 1703-1711 (2004).
22. Redon, C. et al. Yeast histone 2A serine 129 is essential for the efficient repair of checkpoint-blind DNA damage. EMBO Rep. 4, 678-684 (2003).
23. Mirzayans, R., Severin, D. & Murray, D. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 66, 1498-1505 (2006).
24. Chowdhury, D. et al. γH2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol. Cell 20, 801-809 (2005).
25. Keogh, M. C. et al. A phosphatase complex that dephosphorylates γH2AX regulates DNA damage checkpoint recovery. Nature 439, 497-501 (2006).
26. Chowdhury, D. et al. A PP4-phosphatase complex dephosphorylates γH2AX generated during DNA replication. Mol. Cell 31, 33-46 (2008).
27. Nakada, S., Chen, G. I., Gingras, A. C. & Durocher, D. PP4 is a γH2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep. 9, 1019-1026 (2008).
28. Downs, J. A. et al. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol. Cell 16, 979-990 (2004).
29. Morrison, A. J. et al. INO80 and γH2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. Cell 119, 767-775 (2004).
30. Kusch, T. et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306, 2084-2087 (2004).
31. van Attikum, H., Fritsch, O., Hohn, B. & Gasser, S. M. Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair. Cell 119, 777-788 (2004).
32. van Attikum, H. & Gasser, S. M. ATP-dependent chromatin remodeling and DNA double-strand break repair. Cell Cycle 4, 1011-1014 (2005).
33. Stiff, T. et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25, 5775-5782 (2006).
34. Marti, T. M., Hefner, E., Feeney, L., Natale, V. & Cleaver, J. E. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc. Natl Acad. Sci. USA 103, 9891-9896 (2006).
35. Hanasoge, S. & Ljungman, M. H2AX phosphorylation after UV-irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis 28, 2298-2304 (2007).
36. Bassing, C. H. et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl Acad. Sci. USA 99, 8173-8178 (2002).
37. Bassing, C. H. et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359-370 (2003).
38. Thirman, M. J. et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med. 329, 909-914 (1993).
39. Parikh, R. A. et al. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46, 761-775 (2007).
40. Srivastava, N., Gochhait, S., Gupta, P. & Bamezai, R. N. Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet. Cytogenet. 180, 121-128 (2008 ).
41. Novik, K. L. et al. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 16, 1098-1106 (2007).
42. Liu, Y. et al. Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res. 67, 2685-2692 (2007).
43. Celeste, A. et al. Genomic instability in mice lacking histone H2AX. Science 296, 922-927 (2002).
44. Celeste, A. et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371-383 (2003).
45. Goodarzi, A. A. et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31, 167-177 (2008).
46. Ghiassi-nejad, M., Mortazavi, S. M., Cameron, J. R., Niroomand-rad, A. & Karam, P. A. Very high background radiation areas of Ramsar, Iran: preliminary biological studies. Health Phys. 82, 87-93 (2002).
47. Desai, N., Durante, M., Lin, Z. W., Cucinotta, F. & Wu, H. High LET-induced H2AX phosphorylation around the Bragg curve. Adv. Space Res. 35, 236-242 (2005).
48. Brenner, D. J. & Ward, J. F. Constraints on energy deposition and target size of multiply damaged sites associated with DNA double-strand breaks. Int. J. Radiat. Biol. 61, 737-748 (1992).
49. Hagen, U. Mechanisms of induction and repair of DNA double-strand breaks by ionizing radiation: some contradictions. Radiat. Environ. Biophys. 33, 45-61 (1994).
50. Bonner, W. M. Phenomena leading to cell survival values which deviate from linear-quadratic models. Mutat. Res. 568, 33-39 (2004).
51. Kielbassa, C., Roza, L. & Epe, B. Wavelength dependence of oxidative DNA damage induced by UV and visible light. Carcinogenesis 18, 811-816 (1997).
52. Klaunig, J. E. & Kamendulis, L. M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44, 239-267 (2004).
53. Tanaka, T., Halicka, H. D., Huang, X., Traganos, F. & Darzynkiewicz, Z. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 5, 1940-1945 (2006).
54. Hussain, S. P., Hofseth, L. J. & Harris, C. C. Radical causes of cancer. Nature Rev. Cancer 3, 276-285 (2003).
55. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. & Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 121, 2381-2386 (2007).
56. Burhans, W. C. & Weinberger, M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 35, 7545-7556 (2007).
57. Sobol, R. W. et al. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J. Biol. Chem. 278, 39951-39959 (2003).
58. Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nature Rev. Cancer 6, 789-802 (2006).
59. Yamashita, Y. et al. Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Biochemistry 31, 12069-12075 (1992).
60. Pourquier, P. & Pommier, Y. Topoisomerase I-mediated DNA damage. Adv. Cancer Res. 80, 189-216 (2001).
61. McClendon, A. K. & Osheroff, N. DNA topoisomerase II, genotoxicity, and cancer. Mutat. Res. 623, 83-97 (2007).
62. Fortune, J. M. & Osheroff, N. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog. Nucleic Acid Res. Mol. Biol. 64, 221-253 (2000).
63. Guirouilh-Barbat, J., Redon, C. & Pommier, Y. Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex. Mol. Biol. Cell 19, 3969-3981 (2008).
64. Wilson, D. M. 3rd & Bohr, V. A. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst.) 6, 544-559 (2007).
65. Nowosielska, A. & Marinus, M. G. DNA mismatch repair-induced double-strand breaks. DNA Repair (Amst.) 7, 48-56 (2008).
66. McCulloch, S. D. & Kunkel, T. A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18, 148-161 (2008).
67. Kraemer, K. H. et al. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145, 1388-1396 (2007).
68. Andressoo, J. O., Hoeijmakers, J. H. & Mitchell, J. R. Nucleotide excision repair disorders and the balance between cancer and aging. Cell Cycle 5, 2886-2888 (2006).
69. Cheadle, J. P. & Sampson, J. R. Exposing the MYtH about base excision repair and human inherited disease. Hum. Mol. Genet. 12, R159-R165 (2003).
70. Rustgi, A. K. The genetics of hereditary colon cancer. Genes Dev. 21, 2525-2538 (2007).
71. Campisi, J. & d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nature Rev. Mol. Cell Biol. 8, 729-740 (2007).
72. d'Adda di Fagagna, F. Living on a break: cellular senescence as a DNA-damage response. Nature Rev. Cancer 8, 512-522 (2008).
73. Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556 (2003).
74. Nakamura, A. J. et al. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenet. Chromatin (in the press).
75. Deng, Y., Chan, S. S. & Chang, S. Telomere dysfunction and tumour suppression: the senescence connection. Nature Rev. Cancer 8, 450-458 (2008).
76. Edry, E. & Melamed, D. Class switch recombination: a friend and a foe. Clin. Immunol. 123, 244-251 (2007).
77. Soulas-Sprauel, P. et al. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene 26, 7780-7791 (2007).
78. Mahadevaiah, S. K. et al. Recombinational DNA double-strand breaks in mice precede synapsis. Nature Genet. 27, 271-276 (2001).
79. Fernandez-Capetillo, O. et al. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell 4, 497-508 (2003).
80. Rogakou, E. P., Nieves-Neira, W., Boon, C., Pommier, Y. & Bonner, W. M. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J. Biol. Chem. 275, 9390-9395 (2000).
81. Samejima, K. & Earnshaw, W. C. Trashing the genome: the role of nucleases during apoptosis. Nature Rev. Mol. Cell Biol. 6, 677-688 (2005).
82. Tarakanova, V. L. et al. Gammaherpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1, 275-286 (2007).
83. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
84. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
85. 125IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat. Res. 158, 486-492 (2002).
86. Rothkamm, K. & Lobrich, M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl Acad. Sci. USA 100, 5057-5062 (2003).
87. Sedelnikova, O. A. et al. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biol. 6, 168-170 (2004).
88. Lobrich, M. et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc. Natl Acad. Sci. USA 102, 8984-8989 (2005).
89. Qvarnstrom, O. F., Simonsson, M., Johansson, K. A., Nyman, J. & Turesson, I. DNA double strand break quantification in skin biopsies. Radiother. Oncol. 72, 311-317 (2004).
90. Huang, X., Halicka, H. D. & Darzynkiewicz, Z. Detection of histone H2AX phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks). Curr. Protoc. Cytom. Chapter 7 Unit 7.27 (2004).
91. Tanaka, T. et al. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 71, 641-648 (2007).
92. Olive, P. L. & Banath, J. P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 58, 331-335 (2004).
93. Rothkamm, K., Balroop, S., Shekhdar, J., Fernie, P. & Goh, V. Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. Radiology 242, 244-251 (2007).
94. Sedelnikova, O. A. et al. DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res. 67, 4295-4302 (2007).
95. Sedelnikova, O. A. et al. Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell 7, 89-100 (2008).
96. Takagi, K. et al. Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters. Mol. Cancer Ther. 6, 3229-3238 (2007).
97. Albert, J. M. et al. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin. Cancer Res. 13, 3033-3042 (2007).
98. Rao, V. A., Agama, K., Holbeck, S. & Pommier, Y. Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone γ-H2AX as a biomarker of DNA damage. Cancer Res. 67, 9971-9979 (2007).
99. Shimura, T. et al. Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. J. Mol. Biol. 375, 1152-1164 (2008).
100. MacPhail, S. H., Banath, J. P., Yu, Y., Chu, E. & Olive, P. L. Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat. Res. 159, 759-767 (2003).
101. Ismail, I. H., Wadhra, T. I. & Hammarsten, O. An optimized method for detecting γ-H2AX in blood cells reveals a significant interindividual variation in the γ-H2AX response among humans. Nucleic Acids Res. 35, e36 (2007).
102. Olive, P. L., Banath, J. P. & Keyes, M. Residual γH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiother Oncol. 86, 336-346 (2008).
103. Ha, L., Ceryak, S. & Patierno, S. R. Generation of S. phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of γ-H2AX. Carcinogenesis 25, 2265-2274 (2004).
104. Furuta, T. et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278, 20303-20312 (2003).
105. Celeste, A. et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nature Cell Biol. 5, 675-679 (2003).
106. Koturbash, I. et al. Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. Int. J. Radiat. Oncol. Biol. Phys. 66, 327-330 (2006).
107. Xie, A. et al. Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol. Cell 28, 1045-1057 (2007).
108. Joubert, A. et al. DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity? Int. J. Radiat. Biol. 84, 107-125 (2008).
109. Iwabuchi, K. et al. Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA. J. Biol. Chem. 278, 36487-36495 (2003).
110. Jeyapalan, J. C., Ferreira, M., Sedivy, J. M. & Herbig, U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128, 36-44 (2007).
111. Porcedda, P. et al. Impaired elimination of DNA double-strand break-containing lymphocytes in ataxia telangiectasia and Nijmegen breakage syndrome. DNA Repair (Amst.) 5, 904-913 (2006).
112. Tanaka, T., Kajstura, M., Halicka, H. D., Traganos, F. & Darzynkiewicz, Z. Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif. 40, 1-13 (2007).
113. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008).
114. Fagerholm, R. et al. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nature Genet. 40, 844-853 (2008).
115. Yu, T., MacPhail, S. H., Banath, J. P., Klokov, D. & Olive, P. L. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair (Amst.) 5, 935-946 (2006).
116. Wasco, M. J. & Pu, R. T. Utility of antiphosphorylated H2AX antibody (γ-H2AX) in diagnosing metastatic renal cell carcinoma. Appl. Immunohistochem. Mol. Morphol. 16, 349-356 (2008).
117. Lakatos, P. L. & Lakatos, L. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J. Gastroenterol. 14, 3937-3947 (2008).
118. Risques, R. A. et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135, 410-418 (2008).
119. Porcedda, P. et al. A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia. Cytometry A 73, 508-516 (2008).
120. Riballo, E. et al. A pathway of double-strand break rejoining dependent upon, A. T. M., Artemis, and proteins locating to γ-H2AX foci. Mol. Cell 16, 715-724 (2004).
121. Geisel, D., Heverhagen, J. T., Kalinowski, M. & Wagner, H. J. DNA double-strand breaks after percutaneous transluminal angioplasty. Radiology 248, 852-859 (2008).
122. Sak, A. et al. γ-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment. Int. J. Radiat. Biol. 83, 639-652 (2007).
123. Childs, S. & Ling, V. The MDR superfamily of genes and its biological implications. Important Adv. Oncol. 21-36 (1994).
124. Kummar, S. et al. Compressing drug development timelines in oncology using phase '0' trials. Nature Rev. Cancer 7, 131-139 (2007).
125. Karp, J. E. et al. A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias. Blood 110, 1762-1769 (2007).
126. Yauk, C. et al. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc. Natl Acad. Sci. USA 105, 605-610 (2008).
127. Rekhadevi, P. V. et al. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 22, 395-401 (2007).
128. Markova, E., Hillert, L., Malmgren, L., Persson, B. R. & Belyaev, I. Y. Microwaves from GSM mobile telephones affect 53BP1 and γ-H2AX foci in human lymphocytes from hypersensitive and healthy persons. Environ. Health Perspect. 113, 1172-1177 (2005).
129. Briviba, K. et al. Effect of consumption of organically and conventionally produced apples on antioxidant activity and DNA damage in humans. J. Agric. Food Chem. 55, 7716-7721 (2007).
130. Markova, E., Schultz, N. & Belyaev, I. Y. Kinetics and dose-response of residual 53BP1/ γ-H2AX foci: co-localization, relationship with DSB repair and clonogenic survival. Int. J. Radiat. Biol. 83, 319-329 (2007).
131. McManus, K. J. & Hendzel, M. J. ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol. Biol. Cell 16, 5013-5025 (2005).
132. Ward, I. M. & Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276, 47759-47762 (2001).
133. Ichijima, Y. et al. Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. Biochem. Biophys. Res. Commun. 336, 807-812 (2005).
134. Jeffers, L. J., Coull, B. J., Stack, S. J. & Morrison, C. G. Distinct BRCT domains in Mcph1/Brit1 mediate ionizing radiation-induced focus formation and centrosomal localization. Oncogene 27, 139-144 (2008).
135. Chicheportiche, A., Bernardino-Sgherri, J., de Massy, B. & Dutrillaux, B. Characterization of Spo11-dependent and independent phospho-H2AX foci during meiotic prophase I in the male mouse. J. Cell Sci. 120, 1733-1742 (2007).
136. Daniel, R. et al. Histone H2AX is phosphorylated at sites of retroviral DNA integration but is dispensable for postintegration repair. J. Biol. Chem. 279, 45810-45814 (2004).
137. Stiff, T. et al. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64, 2390-2396 (2004).
138. Stucki, M. & Jackson, S. P. γH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes. DNA Repair (Amst.) 5, 534-543 (2006).
139. Kobayashi, J. et al. NBS1 localizes to γ-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 12, 1846-1851 (2002).
140. di Masi, A. et al. The R215W mutation in NBS1 impairs γ-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem. Biophys. Res. Commun. 369, 835-840 (2008).
141. Lou, Z. et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21, 187-200 (2006).
142. Wood, J. L., Singh, N., Mer, G. & Chen, J. MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. J. Biol. Chem. 282, 35416-35423 (2007).
143. Alderton, G. K. et al. Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nature Cell Biol. 8, 725-733 (2006).
144. Chaplet, M., Rai, R., Jackson-Bernitsas, D., Li, K. & Lin, S. Y. BRIT1/MCPH1: a guardian of genome and an enemy of tumors. Cell Cycle 5, 2579-2583 (2006).
145. Fernandez-Capetillo, O., Lee, A., Nussenzweig, M. & Nussenzweig, A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 3, 959-967 (2004).
146. Ikura, T. et al. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol. Cell Biol. 27, 7028-7040 (2007).
147. van Attikum, H., Fritsch, O. & Gasser, S. M. Distinct roles for SWR1 and INO80 chromatin remodeling complexes at chromosomal double-strand breaks. EMBO J. 26, 4113-4125 (2007).
148. Xie, A. et al. Control of sister chromatid recombination by histone H2AX. Mol. Cell 16, 1017-1025 (2004).
149. Unal, E. et al. DNA damage response pathway uses histone modification to assemble a double-strand break-specific cohesin domain. Mol. Cell 16, 991-1002 (2004).
150. Lu, C. et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol. Cell 23, 121-132 (2006).
151. Lu, C. et al. Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. FEBS Lett. 582, 2703-2708 (2008).
152. Marchetti, F., Coleman, M. A., Jones, I. M. & Wyrobek, A. J. Candidate protein biodosimeters of human exposure to ionizing radiation. Int. J. Radiat. Biol. 82, 605-639 (2006).
153. Banath, J. P. & Olive, P. L. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res. 63, 4347-4350 (2003).
154. Tomilin, N. V. et al. Visualization of focal nuclear sites of DNA repair synthesis induced by bleomycin in human cells. Radiat. Res. 156, 347-354 (2001).
155. Antony, S. et al. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Cancer Res. 67, 10397-10405 (2007).
156. Olive, P. L., Banath, J. P. & Sinnott, L. T. Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide. Cancer Res. 64, 5363-5369 (2004).
157. Kurz, E. U. & Lees-Miller, S. P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst.) 3, 889-900 (2004).
158. Krynetskaia, N., Xie, H., Vucetic, S., Obradovic, Z. & Krynetskiy, E. High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs. Mol. Pharmacol. 73, 260-269 (2008).
159. Ewald, B., Sampath, D. & Plunkett, W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol. Cancer Ther. 6, 1239-1248 (2007).
160. Kurose, A. et al. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis. Cytometry A 69, 212-221 (2006).
161. Pabla, N., Huang, S., Mi, Q. S., Daniel, R. & Dong, Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J. Biol. Chem. 283, 6572-6583 (2008).
162. Mirzoeva, O. K., Kawaguchi, T. & Pieper, R. O. The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity. Mol. Cancer Ther. 5, 2757-2766 (2006).
163. Meng, L., Kohlhagen, G., Sausville, E. A. & Pommier, Y. DNA-protein crosslinks and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against breast cancer cells. Cancer Res. 65, 5337-5343 (2005).
164. Kiziltepe, T. et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol. Cancer Ther. 6, 1718-1727 (2007).
165. Munshi, A. et al. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci. Mol. Cancer Ther. 5, 1967-1974 (2006).
166. Zhao, Y. et al. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 66, 5354-5362 (2006).
167. Solier, S., Sordet, O., Kohn, K. W. & Pommier, Y. Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways. Mol. Cell Biol. (in the press).